Cellular tumor antigen p53
Cellular tumor antigen p53 (193-204) is a synthetic peptide fragment derived from the highly conserved tumor suppressor protein p53, encompassing amino acid residues 193 through 204. As a critical segment of the p53 protein, this peptide includes part of the DNA-binding domain, a region essential for the protein's regulatory functions in cell cycle control, apoptosis, and genomic stability. Due to its pivotal role in maintaining cellular homeostasis and its frequent mutation in various cancers, the p53 pathway—and its constituent peptides—are of central interest in molecular biology, cancer research, and biochemical assay development. The 193-204 fragment, in particular, serves as a valuable tool for probing the structural and functional dynamics of p53, enabling researchers to dissect specific interactions and modifications that influence cellular outcomes.
Epitope mapping: Researchers utilize the 193-204 peptide fragment to precisely identify and characterize antibody binding sites within the p53 protein. By employing this defined sequence in immunological assays such as ELISA or Western blot, investigators can determine the specificity of monoclonal and polyclonal antibodies raised against p53, facilitating the development of highly selective reagents for detection and quantification of p53 in biological samples. This approach aids in distinguishing between wild-type and mutant forms of the protein, which is particularly relevant in tumor profiling and basic cancer studies.
Protein-protein interaction studies: The peptide serves as a model substrate to examine interactions between p53 and its regulatory partners, including MDM2, p300, and various transcriptional co-factors. By incorporating the 193-204 fragment into in vitro binding assays or structural studies, scientists can elucidate the molecular determinants governing these associations. Such investigations provide insight into the mechanisms by which p53 activity is modulated, supporting the rational design of molecules that can influence these critical protein-protein interfaces.
Post-translational modification analysis: The defined sequence of the 193-204 peptide makes it an ideal substrate for studying specific post-translational modifications, such as phosphorylation or acetylation, that occur within this region of p53. Researchers can use the peptide in kinase or acetyltransferase assays to assess enzyme specificity, map modification sites, and explore the functional consequences of these biochemical alterations. Understanding how modifications within this domain affect p53 function is crucial for unraveling the regulatory networks that control cell fate decisions.
Structural biology applications: The 193-204 peptide fragment is frequently employed in structural studies, including NMR spectroscopy and crystallography, to model local conformational changes and interaction motifs within the p53 DNA-binding domain. By analyzing the isolated peptide, scientists gain a clearer view of secondary structure elements, flexibility, and solvent accessibility, which informs broader efforts to resolve the three-dimensional structure of full-length p53 and its complexes with nucleic acids or regulatory proteins.
Peptide-based assay development: The availability of a well-defined p53-derived peptide enables the creation of robust biochemical assays for high-throughput screening, inhibitor testing, or functional analysis. For example, the 193-204 fragment can be incorporated into fluorescence polarization, surface plasmon resonance, or other biophysical platforms to monitor binding events and enzymatic modifications in real time. Such assays are instrumental in identifying novel modulators of p53 activity and advancing translational research focused on cell cycle regulation and tumor suppression.
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More